LeMaitre Vascular, Inc.
LMAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,069 | $1,261 | $1,011 | $1,063 |
| - Cash | $26 | $24 | $19 | $14 |
| + Debt | $186 | $19 | $17 | $16 |
| Enterprise Value | $2,229 | $1,256 | $1,009 | $1,065 |
| Revenue | $220 | $193 | $162 | $154 |
| % Growth | 13.6% | 19.7% | 4.7% | – |
| Gross Profit | $151 | $127 | $105 | $101 |
| % Margin | 68.6% | 65.7% | 64.9% | 65.7% |
| EBITDA | $67 | $49 | $37 | $46 |
| % Margin | 30.4% | 25.3% | 22.8% | 29.8% |
| Net Income | $44 | $30 | $21 | $27 |
| % Margin | 20% | 15.6% | 12.8% | 17.4% |
| EPS Diluted | 1.93 | 1.34 | 0.93 | 1.25 |
| % Growth | 44% | 44.1% | -25.6% | – |
| Operating Cash Flow | $44 | $37 | $25 | $35 |
| Capital Expenditures | -$7 | -$7 | -$3 | -$5 |
| Free Cash Flow | $37 | $29 | $22 | $30 |